Fact CheckerSign in

NCT07188064Recruiting

A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery

Prospective Cohort Study of Somatic-Autonomic Nerve Grafting Technique to Restore Erectile Function in Patients With Persistent Erectile Dysfunction Post Radical Prostatectomy

Source: ClinicalTrials.gov · Last updated 10 Mar 2026

Brief summary (registry, in English)

A single arm prospective pilot trial evaluating the 1-year erectile recovery outcomes and the safety of patients undergoing a somatic to autonomic nerve grafting procedure for restoration of erectile function in patients who have lost erectile function following radical prostatectomy for prostate cancer. During this study a total of 100 patients who have persistent erectile dysfunction for more than 18 months post prostatectomy will undergo a post radical prostatectomy nerve restoration procedure (PRP-NR).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
15 Sept 2025
Start date
30 Jan 2026
Primary completion date
Nov 2028
Lead sponsor
Sir Mortimer B. Davis - Jewish General Hospital
NCT number
NCT07188064

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 30 Jan 2026 to the primary completion date, Nov 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pre-existing penile base surgery which would prevent grafting technique including suprapubic liposuction, suspensory ligament release
  • Current use of androgen deprivation therapy
  • Use of medications for chronic nerve pain (gabapentin, amitriptyline, nortriptyline, pregablin)
  • Previous untreated penile trauma
  • Patients deemed medically unfit for surgery

Other illness

  • Patients with pre-existing significant neurologic disease
  • Diabetes with evidence of peripheral nerve involvement and end organ dysfunction
  • Coronary artery disease with unstable angina
  • Mood disorder (anxiety/depression) with change in medical therapy within last 3 months

Age

  • Patients aged \< 18 years at diagnosis
  • Patients \>5 years from prostatectomy.

Other

  • Legally incapable patients
  • Bilateral open inguinal hernia repair
  • Pre-existing penile prosthesis

Who the study is looking for

  • Patients with persistent post prostatectomy erectile dysfunction as defined below:
    • Severe ED (IIEF score 5-7) and more than 12 months from prostatectomy OR
    • Moderate ED (IIEF score 8-11) and more than 18 months from prostatectomy
  • Patients must have had good pre-prostatectomy erectile function with a baseline IIEF score of ≥17 on self-reported assessment of historic function.

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Jewish General Hospital
Coordinator of this site? Confirm its status
MontrealCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.